trial · primary record
RUXIENCE®.
Primary Angiitis of the Central Nervous System (PACNS) in Remission
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 74 |
| Primary completion | 2032-01-01 |
| Primary endpoint | To determine the superiority of rituximab over azathioprine for maintenance therapy in patients with primary angiitis of central nervous system |
| Registry ID | NCT07902492 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:36.935Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07902492
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.